Pharma Foods International Co., Ltd. (TYO:2929)
Japan · Delayed Price · Currency is JPY 691.00
-1.00 (-0.14%)
Sep 14, 2026, 3:30 PM JST
TYO:2929 Ratios and Metrics
Market cap in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
| 20,069 | 16,206 | 25,612 | 30,908 | 48,344 | 42,491 | |
Market Cap Growth | -19.27% | -36.72% | -17.14% | -36.07% | 13.78% | -49.52% |
Enterprise Value | 29,449 | 24,652 | 28,535 | 33,591 | 54,775 | 47,604 |
Last Close Price | 691.00 | 558.00 | 852.21 | 1029.62 | 1531.64 | 1318.40 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
PE Ratio | 10.07 | 8.15 | 69.60 | 9.64 | 15.69 | - |
Forward PE | 12.70 | 10.52 | - | - | - | - |
PS Ratio | 0.32 | 0.26 | 0.39 | 0.50 | 0.71 | 0.71 |
PB Ratio | 1.52 | 1.23 | 2.22 | 2.67 | 5.02 | 6.01 |
P/TBV Ratio | 1.53 | 1.24 | 2.24 | 2.71 | 5.15 | 6.28 |
P/FCF Ratio | - | - | - | 6.65 | 8.42 | - |
P/OCF Ratio | - | - | - | 5.63 | 7.89 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
EV/Sales Ratio | 0.47 | 0.39 | 0.44 | 0.54 | 0.80 | 0.79 |
EV/EBITDA Ratio | 9.37 | 7.37 | 9.05 | 5.58 | 13.18 | 29.75 |
EV/EBIT Ratio | 12.12 | 9.36 | 12.05 | 6.57 | 15.17 | 44.08 |
EV/FCF Ratio | - | - | - | 7.23 | 9.54 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Debt / Equity Ratio | 1.30 | 1.30 | 1.09 | 1.46 | 2.09 | 2.38 |
Debt / EBITDA Ratio | 5.13 | 5.13 | 4.00 | 2.81 | 4.84 | 10.54 |
Debt / FCF Ratio | - | - | - | 3.64 | 3.50 | - |
Net Debt / Equity Ratio | 0.71 | 0.71 | 0.30 | 0.11 | 0.39 | 1.13 |
Net Debt / EBITDA Ratio | 2.80 | 2.80 | 1.10 | 0.20 | 0.91 | 5.01 |
Net Debt / FCF Ratio | - | - | -1.75 | 0.26 | 0.66 | -1.23 |
Asset Turnover | 1.87 | 1.87 | 1.89 | 1.71 | 2.04 | 2.31 |
Inventory Turnover | 1.48 | 1.48 | 1.74 | 2.10 | 2.19 | 2.74 |
Quick Ratio | 0.65 | 0.65 | 0.72 | 0.86 | 0.86 | 0.71 |
Current Ratio | 1.26 | 1.26 | 1.19 | 1.18 | 1.13 | 1.03 |
Return on Equity (ROE) | 16.09% | 16.09% | 3.18% | 30.21% | 36.89% | -4.81% |
Return on Assets (ROA) | 4.86% | 4.86% | 4.28% | 8.78% | 6.70% | 2.59% |
Return on Invested Capital (ROIC) | 10.95% | 11.98% | 2.57% | 24.83% | 22.03% | -3.04% |
Return on Capital Employed (ROCE) | 15.60% | 15.60% | 18.70% | 38.10% | 30.40% | 12.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Earnings Yield | 9.91% | 12.27% | 1.44% | 10.37% | 6.37% | -0.88% |
FCF Yield | -22.61% | - | -7.74% | 15.03% | 11.87% | -15.37% |
Dividend Yield | 3.61% | - | 2.93% | 2.43% | 1.44% | 1.52% |
Payout Ratio | - | - | 213.04% | 19.53% | 18.76% | - |
Buyback Yield / Dilution | -0.82% | -0.82% | -1.06% | 1.51% | 0.47% | 0.18% |
Total Shareholder Return | 2.79% | -0.82% | 1.87% | 3.94% | 1.91% | 1.70% |